Taken together, these results confirm the potential of SFRP1 to act as a tumor suppressor in basal-like triple-negative breast cancer, notably by reducing both canonical (Figure 6E) and non-canonical (Figure 6F) Wnt signaling pathways. This evidence concerns the gene SFRP1 and neoplasm.